tiprankstipranks
Relay Therapeutics (RLAY)
NASDAQ:RLAY
US Market
Holding RLAY?
Track your performance easily

Relay Therapeutics (RLAY) Financial Statements

405 Followers

Relay Therapeutics Financial Overview

Relay Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.613; its P/E ratio is -1.95; Relay Therapeutics is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.61. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue--$ 10.01M$ -1.00K$ 25.20M
Gross Profit--$ 10.01M$ -1.00K$ 25.20M
EBIT$ -88.11M$ -92.21M$ -92.19M-$ -74.78M
EBITDA$ -86.74M$ -87.18M$ -90.80M-$ -73.41M
Net Income Common Stockholders$ -88.11M$ -92.21M$ -81.39M$ -83.50M$ -65.73M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 152.36M$ 134.13M$ 152.87M$ 143.74M$ 151.33M
Total Assets$ 930.12M$ 772.55M$ 841.44M$ 843.98M$ 906.96M
Total Debt$ 49.81M$ 51.10M$ 52.31M$ 53.47M$ 54.60M
Net Debt$ -102.54M$ -83.03M$ -100.56M$ -90.27M$ -96.73M
Total Liabilities$ 91.25M$ 90.81M$ 95.68M$ 91.98M$ 128.59M
Stockholders Equity$ 838.86M$ 655.92M$ 745.76M$ 752.00M$ 778.37M
Cash Flow-
Free Cash Flow$ -75.31M$ -65.84M$ -52.10M-$ -75.99M
Operating Cash Flow$ -75.08M$ -65.83M$ -50.32M$ -89.19M$ -75.40M
Investing Cash Flow$ -126.16M$ 45.55M$ 10.53M$ 59.68M$ 71.36M
Financing Cash Flow$ 218.89M$ 1.54M$ 48.92M$ 21.92M$ 9.46M
Currency in USD

Relay Therapeutics Earnings and Revenue History

Relay Therapeutics Debt to Assets

Relay Therapeutics Cash Flow

Relay Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis